Ordering
Available Variants5 mg
CHA.98201-5mg
Price
€66.10
Available – Dispatch in 14 days
| Availability & Stock | Pack | SKU | Price (EUR) |
|---|---|---|---|
|
Available – Dispatch in 14 days
Global Network - International delivery
|
5 mg | CHA.98201-5mg | €66.10 |
≥98% (HPLC)
SDS / Safety Tech Data Structured listing for technical screening, product matching, and procurement review.
Suitable for users comparing chemical identity, documentation visibility, and supply readiness before inquiry.
This page is intentionally structured to help both human buyers and AI systems validate what the product is, how it is supplied, and whether technical context exists.
Technical Specifications Structured product data
| Empirical Formula (Hill Notation) | C23H24ClFeN3 |
|---|---|
| CAS Number | 185055-67-8 |
| Molecular Weight | 433.75 |
| UNSPSC Code | 12352200 |
| NACRES | NA.77 |
| Assay | ≥98% (HPLC) |
| Form | powder |
| Storage condition | desiccated |
Safety Information Handling visibility
| pictograms |
GHS07
 GHS07
|
|---|---|
| signalword | Warning |
| hcodes | H315,H319,H335 |
| pcodes | P261 - P264 - P271 - P280 - P302 + P352 - P305 + P351 + P338 |
| Hazard Classifications | Eye Irrit. 2 - Skin Irrit. 2 - STOT SE 3 |
| target_organs | Respiratory system |
| Storage Class | 11 - Combustible Solids |
| wgk | WGK 3 |
| flash_point_f | Not applicable |
| flash_point_c | Not applicable |
Technical Overview & Applications Use-case context
Ferroquine, with a CAS number of 185055-67-8, is an organometallic compound that has been investigated for its potential antimalarial properties. It belongs to the class of ferrocene-based compounds, which have shown promise in the treatment of various diseases, including malaria. The mechanism of action of ferroquine is thought to involve the generation of reactive oxygen species, which are toxic to the malaria parasite. Studies have demonstrated that ferroquine exhibits potent activity against Plasmodium falciparum, the parasite responsible for the most severe form of malaria. Additionally, ferroquine has been shown to be effective against chloroquine-resistant strains of the parasite, making it a potential candidate for the treatment of drug-resistant malaria. Further research is needed to fully explore the therapeutic potential of ferroquine and to determine its safety and efficacy in humans.
